Sexuality in @entity1 with XXXX , @entity195 , and other @entity303 .

@entity1 @entity323 @entity146 @entity303 @entity73 @entity191 @entity1316 @entity23 @entity74 @entity158 @entity195 @entity4943 @entity5433 @entity25 @entity250
UNASSIGNED: @entity250 ( @entity250 ) is common among @entity1 with @entity191 ( @entity191 ), @entity195 ( @entity195 ), and other @entity303 . Sexual functioning and well-being of @entity1 with @entity191 and their partners are affected by many factors, including motor disabilities, non-motor symptoms (e.g., @entity5433 , @entity25 , @entity1316 , @entity73 , @entity158 , and @entity74 ), medication effects, and relationship issues. The common sexual problems are decreased desire, @entity323 , difficulties in reaching orgasm, and sexual dissatisfaction. Hypersexuality is one of a broad range of @entity23 reported in @entity191 , attributed to antiparkinsonian therapy, mainly dopamine agonists. Involvement of a multidisciplinary team may enable a significant management of hypersexuality. Data on @entity250 in demented @entity1 are scarce, mainly reporting reduced frequency of sex and @entity323 . Treatment of @entity250 is advised at an early stage. @entity146 , including inappropriate @entity146 (ISB), are distressing for @entity1 and their caregivers and may reflect the prevailing behavior accompanying @entity303 ( @entity4943 associated with hyposexuality). The neurobiologic basis of ISB is still only vaguely understood but assessment and intervention are recommended as soon as ISB is suspected. Management of ISB in @entity303 demands a thorough evaluation and understanding of the behavior, and can be treated by non-pharmacologic and pharmacologic interventions.
